Business Standard

Ranbaxy Laboratories reports standalone net loss of Rs 368.26 crore in the September 2014 quarter

Image

Capital Market

Sales decline 7.90% to Rs 1272.69 crore

Net Loss of Ranbaxy Laboratories reported to Rs 368.26 crore in the quarter ended September 2014 as against net loss of Rs 842.23 crore during the previous quarter ended September 2013. Sales declined 7.90% to Rs 1272.69 crore in the quarter ended September 2014 as against Rs 1381.84 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales1272.691381.84 -8 OPM %-12.23-7.37 -PBDT-272.48-168.60 -62 PBT-332.63-263.01 -26 NP-368.26-842.23 56

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 29 2014 | 8:07 AM IST

Explore News